Second Diagnostic Opinions in Sarcoma Linked to Improved Survival Outcomes Phase 2 trial results show anlotinib with anthracyclines and ifosfamide yields a 30.8% ORR and an 82.7% DCR in advanced soft ...

For the last three decades, breakthroughs have been sparse for soft tissue sarcomas, which are rare cancers that affect muscles, fat and other connective tissues. Today, a global team of researchers ...

Ravin Ratan, MD, MEd, of The University of Texas MD Anderson Cancer Center, explains the origins of soft tissue sarcomas within the body—which account for 1% of cancers in adult patients—how they are ...

This retrospective cohort study of limb-sparing eSTS resections integrated clinical variables and radiomic features, including eSTS and limb dimensions. Target outcomes included surgical site ...